XCL1 antibody
Quick Overview for XCL1 antibody (ABIN116136)
Target
See all XCL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- This antibody reacts with human Lymphotactin.
-
Purification
- Affinity chromatography.
-
Immunogen
- Highly pure (>98%) recombinant hLymphotactin
-
-
-
-
Application Notes
-
Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity ofhLymphotactin (60 ng/mL), a concentration of 1.7 - 3.0 μg/mL of this antibody is required. ELISA: To detect hLymphotactin by direct ELISA (using 100l/well antibody solution) aconcentration of at least 0.5g/mL of this antibody is required. This antigen affinity purifiedantibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 -0.4 ng/well of recombinant hLymphotactin. Western Blot: To detect hLymphotactin by Western Blot analysis this antibody can be usedat a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondaryreagents the detection limit for recombinant hLymphotactin is 1.5 - 3.0 ng/lane, undereither reducing or non-reducing conditions.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore in sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- PBS, pH 7.2 without preservatives.
-
Preservative
- Without preservative
-
Handling Advice
- Avoid repeated freezing and thawing. Centrifuge vial prior to opening!
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
-
-
- XCL1 (Chemokine (C Motif) Ligand 1 (XCL1))
-
Alternative Name
- XCL1 / Lymphotactin
-
Background
- Synonyms: ATAC, C motif chemokine 1, Cytokine SCM-1, LTN, Lymphotaxin, SCM-1-alpha, SCYC1, Small-inducible cytokine C1, XC chemokine ligand 1
-
Gene ID
- 6375
-
NCBI Accession
- NP_002986
-
UniProt
- P47992
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-